HPV Positive with a Normal Pap Smear: What Next?
What does it mean to be HPV positive but have a normal smear result?
When an HPV test is positive and a smear test is normal, the two tests answer different questions: the HPV test looks for the presence of high-risk virus types in the sample; the smear evaluates whether there are any abnormal changes in the cells taken from the cervix. Therefore, the results are not contradictory. The virus may be detected, but no changes may be seen in the examined cells. A normal smear does not indicate the absence of HPV or that further follow-up is not necessary. A positive HPV result alone is not a diagnosis of cancer. The NCI's information on abnormal screening results clarifies this distinction.
When you first read the report, the word "positive" might overshadow all other information. However, to determine the next step, the type information, cytology statement, previous results, and personal health history should be read together. This is why it's possible to recommend different follow-ups for two people who gave samples on the same day. Instead of ignoring the result or assuming immediate action is necessary, the complete report should be reviewed with a gynecologist. Leaving the consultation with a defined next step and follow-up date reduces uncertainty.
The difference between HPV test and smear test
An HPV test is a screening test that helps assess the risk associated with the virus. A smear, also known as a Pap test, is the examination of cells in a laboratory; this examination is called cytology. Although both tests can be performed using the same sample collection process, their reports contain different information. Interpreting the smear test and the HPV test as a single, interchangeable result can lead to misunderstandings in the follow-up plan. A normal result on one test does not negate a finding on the other.
If the reports were prepared on different dates, it is helpful to compare the sample collection dates. An old normal smear and a new HPV positivity result are not the same information if evaluated together in the same sample. The physician will want to see the details of the laboratory report if necessary. Bringing the full document instead of just a short notification on the phone screen saying "normal" or "positive" can reduce the need for re-evaluation due to missing information. Where the test was taken and for what purpose should also be stated during the consultation.
What does NILM mean in a smear test report?
NILM is a cytology statement indicating that no intraepithelial lesions or findings suggestive of malignancy were observed in the examined cells. In everyday language, a "normal smear" usually refers to this result. However, the adequacy of the sample should also be checked. The terms "insufficient material" or "inadequate for evaluation" are not equivalent to a normal result. A sample from which cells could not be examined does not provide the same assurance that there is no abnormality. The 2023 update of the ASCCP addresses the re-evaluation of insufficient cytology as a separate topic.
The mere mention of inflammation or other benign findings in the report's explanation section does not, by itself, explain the cause of HPV. The relationship between these statements and the symptoms must be evaluated separately. For example, a person with itching and discharge may require investigation based on the symptoms, but improvement in symptoms does not eliminate the need for HPV monitoring. A practical question to ask the doctor is: "Is my cytology truly adequate and consistent with NILM, or is there a situation requiring a repeat sample collection?" This clarifies the meaning of the word "normal" in the report.
HPV 16 or HPV 18 positive, but the smear is normal.
HPV 16 and HPV 18 are high-risk types that may require further evaluation despite normal cytology. The Turkish Ministry of Health's screening approach includes expert evaluation and referral for colposcopy in cases of positivity for these types. The ASCCP risk-based framework also recommends colposcopy in cases of HPV 16/18 positivity despite normal cytology. Therefore, the idea of "my smear is normal, I can wait a year" cannot be applied to all HPV positive results. It is important to read the type information from the report.
This referral does not mean cancer has been found; it indicates that the screening result needs to be evaluated more closely. Colposcopy is a procedure in which the cervix is examined under magnification. When scheduling an appointment, previous tests, the possibility of pregnancy, and whether the cervix has undergone any previous procedures should be shared. Ignoring a positive type by simply getting a new smear is not a suitable alternative. Understanding the purpose of the procedure makes it easier to participate in the preparation and follow-up process.
Follow-up for high-risk HPV types other than HPV 16 and 18.
If a high-risk type other than HPV 16/18 is detected, and cytology is adequate and normal, then in individuals without other risk factors, an HPV-based follow-up is usually considered after one year. The Ministry of Health's HPV screening algorithm also includes this distinction. However, previous abnormal results, treatment of high-grade lesions, or characteristics related to immune status may alter the follow-up plan. The term "other type" does not mean risk-free; it describes a different assessment approach.
When a yearly check-up is recommended, it should be clearly stated which test will be repeated. An HPV test, a smear, or both are not the same procedure. It is helpful to schedule the approximate time of the check-up and keep the report. Difficulty in attending the follow-up appointment should be discussed upfront. Who will evaluate the results is also part of the plan; simply getting tested at a lab doesn't guarantee the results will be properly interpreted. The recommended timing can be clarified in writing for each individual case.
Summary of decision when HPV positive, smear normal
The table below shows the key differences between common conditions. It is not a personalized treatment guide; it should not be used alone without considering age, previous screenings, and specific health conditions. Instead of replacing your report, you can use the table to organize questions to ask your doctor.
| Information in the report or story | General approach |
|---|---|
| HPV 16 or 18 positive | Even if the smear test is normal, a colposcopic evaluation may be considered. |
| Other high-risk types and adequate normal cytology | For those at appropriate risk, an HPV-based screening is usually scheduled after one year. |
| Persistent HPV positivity during control | The need for colposcopy is re-evaluated in light of the previous results. |
| Insufficient cytology | A normal smear is not acceptable; repeat sampling or further evaluation will be planned within an appropriate timeframe. |
| Previous high-grade lesion or immunosuppression | Instead of standard screening intervals, personalized follow-up is needed. |
Just because one patient's result resembles another's doesn't mean the same procedure should be performed on the same date. Past results often constitute the unseen part of the report. Therefore, the answer to the question, "My friend had a biopsy, why didn't I?" may not be solely based on today's smear test. Having the doctor explain the findings on which they based their plan, and having you repeat it in a way you understand, can prevent misunderstandings. It's also helpful to record the new reasoning when a decision changes.
If the HPV test comes back positive again a year later
Persistent HPV positivity is evaluated differently than a single initial positive result. During follow-up, type information, cytology, and previous examinations are reviewed together. In Türkiye's screening approach, consecutive positive results for types other than 16/18 may necessitate referral for colposcopy. The ASCCP framework also incorporates persistence and previous results into the risk assessment. Dismissing an HPV result during follow-up simply by stating "smear test is normal again" is inappropriate.
On the other hand, a persistent positive result does not directly indicate cancer development. The purpose of closer examination is to detect any cellular changes and determine the next step. Presenting previous reports in chronological order is particularly helpful in this consultation. Dates, HPV types, and cytology results can be kept in a single file. If the laboratory has changed, the scope of tests used may differ; the comparability of the reports is evaluated by the physician. Interpreting each new positive result as a separate infection or trying to determine who transmitted it goes beyond the information the results can provide.
Why are previous smear and HPV test results important?
Risk-based follow-up doesn't just look at the latest report. A previous negative HPV test, findings from a previous colposcopy, or prior treatment for high-grade lesions can all influence the clinical decision. It's important to specify which test is being referred to when someone says, "My check-up last year was normal": a simple examination, smear, HPV test, and biopsy are all different types of information. Understanding the names of the tests performed as part of cervical screening makes this distinction easier.
If you cannot access previous reports, state this clearly. Knowing that the document is unavailable allows for a more accurate assessment than presenting a forgotten result as a definitive negative. The pathology report is also important if a procedure such as LEEP or conization has been performed previously. The control interval may differ from the routine screening interval announced for the general population. The five-year interval specified by the Ministry of Health for routine HPV screening in the 30–65 age group does not automatically apply to individual follow-up of positive or abnormal results.
Are colposcopy and cervical biopsy necessary?
The need for colposcopy is determined by HPV type and overall risk assessment. If suspicious areas are seen during the examination, small tissue samples may be taken. Not every colposcopy is performed in the same way, and being called for a colposcopy does not necessarily mean the biopsy result will be bad. If tissue is taken, pathology provides different information than cytology by evaluating the arrangement of cells within the tissue. The NHS colposcopy information explains that the examination and, if necessary, the biopsy are complementary steps.
Before your appointment, you can ask what will happen during the procedure, what options are available for discomfort, and how the results will be communicated. It's helpful to mention any anxieties, previous difficult examination experiences, or pain beforehand. Consent isn't just about signing a form; it's about understanding which procedure is being recommended and why. Post-procedure care recommendations may vary depending on the procedure performed. You should rely on the instructions given for your specific procedure, rather than relying on recovery time described by someone else on social media.
What should be done if there are symptoms even if the smear test is normal?
Screening tests do not replace diagnostic evaluation based on symptoms. If you experience bleeding after intercourse, bleeding outside of your menstrual cycle, postmenopausal bleeding, or persistent unexplained discharge, you should consult a healthcare professional without waiting for your scheduled appointment. These symptoms can have various causes; a single cause cannot be assumed based solely on an HPV test result. Any accompanying complaints, such as pain during intercourse, should also be described during the evaluation.
Noting when the symptoms started, how frequently they occur, and what they are associated with can facilitate the interview. Emergency evaluation is necessary in cases such as very heavy bleeding, fainting, or severe pain. It is incorrect to view a standard smear test report as a general health certificate ruling out all gynecological diseases. If the symptoms have recently appeared, a recent screening does not render the visit unnecessary. In addition to the results, the patient's current complaint is an important part of the decision.
Is there a treatment that clears HPV positivity?
There is no standard drug treatment that completely eliminates HPV from the body. Treatment is directed at the conditions caused by the virus, such as warts or precancerous lesions, as needed. Antibiotics do not cure HPV. The CDC states that it does not recommend specific antiviral treatment to eliminate asymptomatic infections. Therefore, the distinction between treating HPV-related conditions and simply monitoring a positive test result is important.
The claim that a product “completely eliminates the virus” should not be a reason to discontinue scheduled follow-up. Supplements and other products used should be reported to the physician. If the person smokes, support for quitting can be discussed; the CDC addresses tobacco use as a key area of counseling in relation to the progression of HPV-related diseases. However, healthy lifestyle habits are not a guarantee that the test will be negative by a specific date. Viewing the test result as a measure of whether a person is eating well or behaving correctly creates guilt and is not helpful.
Vaccination and partner counseling when you are HPV positive.
The HPV vaccine does not treat an existing infection or cellular changes; in suitable individuals, it may provide protection against types not yet encountered. The decision to vaccinate is made considering age, previous vaccinations, and personal circumstances. Recommended screening and follow-up continue after HPV vaccination . The NCI's vaccination information separates prevention from treatment of existing infection. Having been vaccinated does not mean that a current positive result is insignificant.
An HPV test result does not definitively show when or from whom the infection was acquired. Because it can be detected after a long period, a positive result is not proof of infidelity. When talking to your partner, it is helpful to differentiate known test results from unknown ones. You can obtain information about the routes of HPV transmission . Condoms can reduce the risk, but they do not provide complete protection as they do not cover all contact areas. Whether a partner needs testing is assessed based on their anatomy and clinical condition; the same screening package is not recommended for everyone.
Monitoring during pregnancy or immunosuppression
If pregnancy is present or planned, this information should be shared during the results evaluation. Necessary colposcopic evaluation can be performed during pregnancy; however, some sampling and treatment methods differ from the approach outside of pregnancy. ASCCP's pregnancy recommendations emphasize separating the need for examination from the decision on treatment. Instead of postponing all evaluations until after delivery or assuming immediate treatment is necessary due to a positive result, a personalized plan should be developed.
Immunosuppressive diseases or medication use should also be mentioned. Routine screening intervals may not be suitable for these individuals. Bringing medication names and information from attending physicians to the discussion ensures a consistent plan is established. Immunotherapy should not be discontinued spontaneously due to an HPV result. Asking the physician, "Is there anything that changes the standard plan for me?" helps separate general internet information from a personal assessment. Where the screening will take place and who the results will be shared with can also be clarified beforehand.
Preparing for your follow-up appointment after testing positive for HPV.
To schedule an appointment, you can gather your HPV report, smear report, previous biopsy or procedure records, and information about medications used. A short list of questions can be prepared: What type was found? Is the cytology sufficient? Is a colposcopy necessary? When should each test be repeated? Knowing who to contact if you don't receive the results will prevent gaps in follow-up. If your follow-up appointment is overdue, apply to schedule a new appointment; openly share the current situation instead of hiding the delay or canceling altogether.
You can prepare your reports for an interview with Assoc. Prof. Dr. Nazlı Korkmaz. This document does not replace a personal follow-up schedule. The medical framework is based on the Ministry of Health's HPV screening algorithm , the HYP Screening and Follow-up Guidelines, ASCCP risk-based guidelines and their 2023 update, and patient information from the NCI, CDC, and NHS. In cases where new test technologies are used, the latest supplementary ASCCP guidelines are also considered; the results of each test are not interpreted using the same method.
Making the follow-up plan sustainable in daily life.
A well-planned HPV follow-up isn't just about making the medical decision. It also requires knowing how to schedule an appointment, when the results will be available, and who to contact for explanation. If you live in a different city or are unable to attend on specific dates due to work, you can mention this upfront. If the follow-up is planned at a different center, it's important to share previous reports. This allows the new healthcare professional to see not only the latest test results but also the reasons for initiating the follow-up and previous decisions.
When organizing your follow-up schedule, it can be helpful to separate two different dates: for example, the date of the test and the appointment for evaluating the results. The result is not automatically interpreted when it appears on the portal. An evaluation by a healthcare professional is necessary, especially if the type information or cytology description changes. Summarizing the plan given at the appointment in your own words can prevent confusion with test names. Therefore, the question, "Should I have just a smear, an HPV test, or both after one year?" is a simple but functional one.
If anxiety about the outcome is significantly impacting your daily life, share this with the doctor during the consultation. Constantly getting tested or using every new online article as a personal risk assessment may not always be reassuring. Making a short list of known findings and unknowns can provide a clearer framework. Including the doctor's recommended next steps in this list, while not completely eliminating uncertainty, makes what to do clearer. Asking questions and seeking clarification throughout the follow-up is part of implementing the recommended plan more safely and accurately.
Frequently Asked Questions
If I test positive for HPV but my smear test is normal, does that mean I have cancer?
This result alone does not constitute a cancer diagnosis. Follow-up or further investigation will be planned based on the HPV type, previous results, and individual risk factors.
My HPV-16 test result is positive but my smear is normal. Can I wait?
A normal smear test for HPV-16 positivity does not eliminate the need for colposcopic evaluation. You should discuss the results with a specialist.
When should we test for other high-risk HPV types?
Under appropriate conditions, an HPV-based screening is usually recommended after one year. Previous results and specific health conditions may alter this timeframe.
Since the smear result was normal, would it be okay not to repeat the HPV test?
Standard cytology does not replace scheduled HPV follow-up. It should be clarified which test will be used for the follow-up.
Can I get vaccinated if I am HPV positive?
Vaccination may be considered in suitable individuals. It does not treat an existing infection and does not eliminate the need for follow-up.
Does a positive HPV result indicate a recent infection?
No. The test cannot definitively determine the time or source of the infection.
Is an insufficient smear result considered normal?
No. Insufficient samples are evaluated separately and may require re-examination or further review at an appropriate time.
If there is bleeding, should I wait for the one-year check-up?
Post-coital bleeding, irregular bleeding, or postmenopausal bleeding should be evaluated without waiting for the scheduled screening date.